EA
PFE icon

Emerald Advisers’s Pfizer PFE Stock Holding History

Emerald Advisers’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,260
Closed -$252K – 282
2021
Q4 		$252K Buy
+4,260
New +$211K 0.01% 223
2015
Q2 		– Sell
-14,228
Closed -$465K – 365
2015
Q1 		$465K Sell
14,228
-2,551
-15% -$81.1K 0.02% 282
2014
Q4 		$496K Sell
16,779
-1,029
-6% -$29.5K 0.03% 273
2014
Q3 		$500K Sell
17,808
-9,668
-35% -$271K 0.03% 273
2014
Q2 		$774K Sell
27,476
-112
-0.4% -$3.19K 0.04% 265
2014
Q1 		$841K Sell
27,588
-2,110
-7% -$62.9K 0.05% 263
2013
Q4 		$863K Buy
29,698
+402
+1% +$11.7K 0.05% 253
2013
Q3 		$798K Buy
29,296
+328
+1% +$8.92K 0.05% 254
2013
Q2 		$770K Buy
+28,968
New +$800K 0.05% 249

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Emerald Advisers's PFE Position: Q1 2022 in Review

Emerald Advisers sold out of Pfizer (PFE) in Q1 2022, closing a stake of 4,260 shares — an estimated $252K sold.

Emerald Advisers first reported a position in PFE in Q2 2013 and held it in 9 quarters. The position peaked at $863K in Q4 2013. 3,195 funds tracked by Wall St. Rank hold PFE as of Q1 2022.

  • Emerald Advisers reported no remaining Pfizer position as of Q1 2022 after selling out during the quarter.
  • Emerald Advisers sold 4,260 Pfizer shares in Q1 2022, an estimated $252K.
  • Emerald Advisers first reported a position in Pfizer in Q2 2013 and held it in 9 quarters.
  • Emerald Advisers's Pfizer position peaked at $863K in Q4 2013.
  • 3,195 funds tracked by Wall St. Rank held Pfizer as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.